These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7906385)

  • 1. Newer purine analogues for the treatment of hairy-cell leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Mar; 330(10):691-7. PubMed ID: 7906385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S
    Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentostatin: impact on outcome in hairy cell leukemia.
    Grever MR
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1099-108. PubMed ID: 16990110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 10. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 11. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
    Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance to purine analogs in hairy cell leukemia.
    Kraut EH
    Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
    [No Abstract]   [Full Text] [Related]  

  • 14. Hairy cell leukemia: update and current therapeutic approach.
    Salam L; Abdel-Wahab O
    Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
    Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
    Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cladribine in the treatment of hairy-cell leukaemia.
    Goodman GR; Beutler E; Saven A
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):101-16. PubMed ID: 12670469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
    Dasanu CA; Alexandrescu DT
    Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.